Advent Capital Management Abb Vie Inc. Transaction History

Advent Capital Management

$155 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $1.55 Million - $1.81 Million	10,000 Added 50.0%	30,000 $5.15 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $1.6 Million - $1.82 Million	-10,000 Reduced 33.33%	20,000 $3.64 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $1.38 Million - $1.55 Million	10,000 Added 50.0%	30,000 $4.65 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $723,050 - $832,700	5,000 Added 33.33%	20,000 $3.19 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $2.07 Million - $2.49 Million	15,000 New	15,000 $2.43 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $5.09 Million - $6.47 Million	-37,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $395,939 - $491,250	-3,000 Reduced 7.5%	37,000 $6 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.06 Million - $1.21 Million	10,000 Added 33.33%	40,000 $4.32 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $3.07 Million - $3.38 Million	30,000 New	30,000 $3.25 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $3.22 Million - $4.35 Million	-40,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $429,550 - $504,150	5,000 Added 14.29%	40,000 $3.5 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $2.57 Million - $3.44 Million	35,000 New	35,000 $3.44 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $538,680 - $637,380	-6,000 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $3.06 Million - $4.1 Million	-33,243 Reduced 84.71%	6,000 $568,000
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $3.07 Million - $3.36 Million	34,243 Added 684.86%	39,243 $3.8 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $349,250 - $446,100	5,000	5,000 $444,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

News

Stay updated on Advent Capital Management with notifications on news.

Account